Charles River Laboratorie
CRL232.5100.90% ( -2.110 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Charles River Laboratorie(CRL) predict that the Revenue is 995.83 M (+1.18%), Beat estimate;the EBIT is 162.65 M (-13.59%), Beat estimate;the EPS is -0.3 (-160%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.00B1.18%
0.98B0.48%
+0.02B1.66%
EBITExceed expectations
0.16B13.59%
0.15B18.86%
+0.01B5.27%
EPSMiss expectations
-0.3160.00%
0.90581.00%
-1.2050241.00%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 5, 2026
Estimate Revenue977.2 M
Estimate EBIT202.47 M
Estimate EPS2.03
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf